<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="rss.xsl"?>
<rss version="2.0">
  <channel>
          <title>Kawasaki Disease - livepress.com</title>
      <link>http://Kawasaki Disease.livepress.com</link>
        <description>Updated every 15 minutes of every day - FOR PERSONAL USE ONLY</description>
    <language>en</language>
    <lastBuildDate/>
    <copyright>Copyright: (C) livepress.com</copyright>
    <docs/>
    <image>
      <title>livepress.com</title>
      <url>http://livepress.com/img/logo-live-press.gif</url>
      <link>http://livepress.com</link>
    </image>

    <item>
      <title><![CDATA[Antibody therapy for Kawasaki disease vary by brand (Reuters)]]></title>
      <link>http://livepress.com/go/?30950</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?30950</guid>
      <pubDate>2006-02-14 16:27:25</pubDate>
      	<description><![CDATA[Reuters - Not all commercially available 
preparations of intravenous immunoglobulin (IVIG), an antibody 
therapy, are equally effective in children with Kawasaki 
disease, an immune system disorder that can cause fever, rash, 
and possible complications of the heart and brain, new research 
shows.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_59572.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
  </channel>
</rss>